Characterization of posttransfusion Plasmodium falciparum infection in semi-immune nonparasitemic patients

Transfusion

Volumn 56, Issue 9, 2016, Pages 2374-2383

  Allain, Jean Pierre ^a   Assennato, Sonny Michael ^a   Osei, Eric N ^b   Owusu Ofori, Alex K ^c   Marschner, Susanne ^d   Goodrich, Raymond P ^d   Owusu Ofori, Shirley ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

^c KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^d Terumo BCT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DILUTION; GENE SEQUENCE; GENOME; HUMAN; HUMORAL IMMUNITY; INFECTION CONTROL; LABORATORY DIAGNOSIS; LEUKOCYTE TRANSFUSION; MALARIA FALCIPARUM; MICROSCOPY; OUTCOME ASSESSMENT; PARASITE CLEARANCE; PARASITE LOAD; PARASITEMIA; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SEROLOGY; TRANSFUSION TRANSMITTED MALARIA;

EID: 84987679996     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13706     Document Type: Article

References (25)

1. Owusu-Ofori AK, Parry C, Bates I. Transfusion-transmitted malaria in countries where malaria is endemic: a review of the literature from sub-Saharan Africa. Clin Infect Dis 2010;51:1192–8.
2. Najem GR, Sulzer AJ. Transfusion-induced malaria from an asymptomatic carrier. Transfusion 1976;16:473–6.
3. Bruce-Chwatt LJ. Transfusion malaria. Bull World Health Organ 1974;50(3-4):337–46.
4. Freimanis G, Sedegah M, Owusu-Ofori S, Kumar S, Allain JP. Investigating the prevalence of transfusion transmission of Plasmodium within hyperendemic blood donation system. Transfusion 2013;53:1429–41.
5. Owusu-Ofori AK, Betson M, Parry CM, Stothard JR, Bates I. Transfusion-transmitted malaria in Ghana. Clin Infect Dis 2013;56:1735–41.
6. Owusu-Ofori S, Kusi J, Owusu-Ofori A, et al. Treatment of whole blood (WB) with riboflavin and UV light: impact on malaria parasite viability and WB storage. Shock 2015;44(suppl 1):33–8.
7. El Chaar M, Atwal S, Freimanis GL, Dinko B, Suthrland CJ, Allain JP. Inactivation of Plasmodium falciparum in whole blood by riboflavin plus irradiation. Transfusion 2013;53:3174–83.
8. Allain JP, Owusu-Ofori AK, Assennato SM, et al. Inactivation of Plasmodium in whole blood reduces the risk of transfusion-transmitted malaria in endemic areas. Lancet 2016;367:1753–61.
9. Singh B, Kim Sung L, Matusop A, et al. A large focus of naturally acquired Plasmodium knowlesi infections in human beings. Lancet 2004;363:1017–24.
10. Bahadur S, Pujani M, Jain M. Use of rapid detection tests to prevent transfusion-transmitted malaria in India. Asian J Transfus Sci 2010;4:140–1.
11. Kitchen AD, Chiodini PL. Malaria and blood transfusion. Vox Sang 2006;90:77–94.
12. Falade CO, Nash O, Akingbola TS, Michael OS, Olojede F, Ademowo OG. Blood banking in a malaria-endemic area: evaluating the problem posed by malarial parasitaemias. Ann Trop Med Parasitol 2009;103:383–92.
13. Gardner MJ, Hall N, Fung E, et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002;419:498–511.
14. Moody A. Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev 2002;15:66–78.
15. Biswas S, Choudhary P, Elias SC, et al. Assessment of humoral immune responses to blood-stage malaria antigens following ChAd63-MVA immunization, controlled human malaria infection and natural exposure. PLoS One 2014;9:e107903.
16. Moncunill G, Mayor A, Jiménez A, et al. High antibody responses against Plasmodium falciparum in immigrants after extended periods of interrupted exposure to malaria. PLoS One 2013;8:e73624.
17. Chan JA, Howell KB, Reiling L, et al. Targets of antibodies against Plasmodium falciparum-infected erythrocytes in malaria immunity. J Clin Invest 2012;122:3227–38.
18. Kinyanjui SM, Mwangi T, Bull PC, Newbold CI, Marsh K. Protection against clinical malaria by heterologous immunoglobulin G antibodies against malaria-infected erythrocyte variant surface antigens requires interaction with asymptomatic infections. J Infect Dis 2004;190:1527–33.
19. Wolofsky KT, Ayi K, Branch DR, et al. ABO blood groups influence macrophage-mediated phagocytosis of Plasmodium falciparum-infected erythrocytes. PLoS Pathog 2012;8:e1002942.
20. Smith TG, Serghides L, Patel SN, Febbraio M, Silverstein RL, Kain KC. CD36-mediated nonopsonic phagocytosis of erythrocytes infected with stage I and IIA gametocytes of Plasmodium falciparum. Infect Immun 2003;71:393–400.
21. Volkman SK, Sabeti PC, DeCaprio D, et al. A genome-wide map of diversity in Plasmodium falciparum. Nat Genet 2007;39:113–9.
22. Kaestli M, Cortes A, Lagog M, Ott M, Beck HP. Longitudinal assessment of Plasmodium falciparum var gene transcription in naturally infected asymptomatic children in Papua New Guinea. J Infect Dis 2004;189:1942–51.
23. Eisen D, Billman-Jacobe H, Marshall VF, Fryauff D, Coppel RL. Temporal variation of the merozoite surface protein-2 gene of Plasmodium falciparum. Infect Immun 1998;66:239–46.
24. Dechavanne C, Pierrat C, Renard E, et al. Genetic characterization of Plasmodium falciparum allelic variants infecting mothers at delivery and their children during their first plasmodial infections. Infect Genet Evol 2013;20:16–25.
25. Ogouyemi-Hounto A, Gazard DK, Ndam N, et al. Genetic polymorphism or merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum isolates from children in South of Benin. Parasite 2013;20:37.